Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia

First posted Oct 27, 2005

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

571 participants · First posted Dec 5, 2005

Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias

63 participants · First posted Dec 18, 2008

Dasatinib(Sprycel)

C₂₂H₂₆ClN₇O₂S · Rx

Bosutinib(Bosulif)

C₂₆H₂₉Cl₂N₅O₃ · Rx

Nilotinib(Tasigna, Nilotinib Accord)

C₂₈H₂₂F₃N₇O · Rx

PHILADELPHIA FIGHT

United States

JAPAN ADULT LEUKEMIA STUDY GROUP

Japan

CHILDREN'S HOSPITAL OF PHILADELPHIA

United States

Cycle Pharmaceuticals Secures Exclusive U.S. Rights to PHYRAGO, Novel Dasatinib Formulation for Leukemia Treatment

FDA Grants Breakthrough Therapy Designation to Olverembatinib for Ph+ Leukemia Treatment

Olverembatinib Shows Promising Results in Multiple Philadelphia Chromosome-Positive ALL Studies